The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXANDERS INC | COM | 014752109 | 7,106,373 | 38,651 | SH | DFND | 1,2 | 38,651 | 0 | 0 | ||
AMPLIFY ENERGY CORP NEW | COM | 03212B103 | 17,340,509 | 2,561,375 | SH | DFND | 1,2,3,4 | 2,561,375 | 0 | 0 | ||
EXELA TECHNOLOGIES INC | 6% CONV PFD SR B | 30162V607 | 317,742 | 77,498 | SH | DFND | 1,2 | 77,498 | 0 | 0 | ||
EYENOVIA INC | COM | 30234E104 | 1,298,303 | 547,807 | SH | DFND | 1,2 | 547,807 | 0 | 0 | ||
FORGE GLOBAL HOLDINGS INC | COM | 34629L103 | 611,164 | 251,508 | SH | DFND | 1,2 | 251,508 | 0 | 0 | ||
FRONTIER COMMUNICATIONS PARE | COM | 35909D109 | 6,662,924 | 357,453 | SH | DFND | 1,2 | 357,453 | 0 | 0 | ||
IMPEL PHARMACEUTICALS INC | COM | 45258K109 | 518,578 | 408,329 | SH | DFND | 1,2 | 408,329 | 0 | 0 | ||
ORCHESTRA BIOMED HLDGS INC | COM | 68572M106 | 426,083 | 60,869 | SH | DFND | 1,2 | 60,869 | 0 | 0 | ||
RANI THERAPEUTICS HLDGS INC | COM CL A | 753018100 | 259,094 | 62,887 | SH | DFND | 1,2 | 62,887 | 0 | 0 | ||
SEADRILL 2021 LTD | COM | G7997W102 | 27,909,498 | 676,266 | SH | DFND | 676,266 | 0 | 0 | |||
SITIO ROYALTIES CORP | CLASS A COM | 82983N108 | 13,326,246 | 507,280 | SH | DFND | 1,2,3,4 | 507,280 | 0 | 0 | ||
VNET GROUP INC | NOTE 2/0 | 90138VAB3 | 1,540,000 | 2,000,000 | PRN | DFND | 2,000,000 | 0 | 0 |